Oorsprong van het eerstegraads netwerk van Anupama Hoey
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 2 | |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA.
2
| Holding Company | Biotechnology | 2 |
Public Company | Biotechnology | 2 | |
Public Company | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Anupama Hoey via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
ARQULE, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Corporate Officer/Principal | |
CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Human Resources Officer | |
DYADIC INTERNATIONAL, INC. | Medical/Nursing Services | President | |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Biotechnology | General Counsel | |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree | |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
INNOVIVA, INC. | Pharmaceuticals: Major | Human Resources Officer | |
Massachusetts Institute of Technology | College/University | Graduate Degree | |
Kansas State University | College/University | Undergraduate Degree | |
State University of New York at Buffalo | College/University | Undergraduate Degree | |
University of California, Riverside | College/University | Doctorate Degree | |
University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
The University of Colorado | College/University | Doctorate Degree | |
University of Bristol | College/University | Doctorate Degree | |
The University of North Carolina at Chapel Hill | College/University | Doctorate Degree | |
Emergent Technologies, Inc.
Emergent Technologies, Inc. Investment ManagersFinance Emergent Technologies, Inc. (Emergent Technologies) is a venture capital firm founded in 1989 by Thomas A. Harlan. The firm is headquartered in Austin. Texas. | Investment Managers | Corporate Officer/Principal | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ACTINOGEN MEDICAL LIMITED | Pharmaceuticals: Other | Director/Board Member | |
IRBM SpA
IRBM SpA BiotechnologyHealth Technology IRBM SpA is a research organization that specializes in drug discovery and development. IRBM is based in Pomezia, IT, and has subsidiaries in Italy. The Italian company produces recombinant proteins in a homogeneous state and use cyclization to pre-organize compounds for target binding. The private company uses nuclear magnetic resonance (NMR) spectroscopy to study structural biology, clinical research solutions, functional genomics, structure/activity relationships, drug discovery, macromolecule, and small-molecule analysis. The company has a screening library of over 320,000 compounds and use virtual screening and NMR to drive innovation. The company was founded in 2010 by Piero di Lorenzo, who has been the CEO since then. | Biotechnology | Director/Board Member | |
Society for Laboratory Automation & Screening
Society for Laboratory Automation & Screening Miscellaneous Commercial ServicesCommercial Services The Society for Laboratory Automation & Screening (SLAS) sets standards for microplate development through its Microplate Standards Advisory Committee. The non-profit company is based in St. Charles, IL. SLAS offers various platforms for education, scientific publishing, collaboration, networking, and career advancement for its international community. The company has developed a new micro-credentials program exclusively for the life sciences industry. SLAS's mission is to connect laboratory technology providers with laboratory technology users. | Miscellaneous Commercial Services | Director/Board Member | |
Taxon Biosciences, Inc.
Taxon Biosciences, Inc. BiotechnologyHealth Technology Taxon Biosciences, Inc. engages in the provision of development of genomics tools to profile microbial communities. The company was founded by Matthew Ashby, Jasper Rine, and Stewart Scherer in 2000 and is headquartered in Wilmington, DE. | Biotechnology | Chief Executive Officer | |
AXCA HEALPAR | Biotechnology | Director/Board Member | |
PERRIGO COMPANY PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
MIT Sloan School of Management | College/University | Masters Business Admin | |
Duke University School of Medicine | College/University | Doctorate Degree | |
Roche Healthcare Ltd.
Roche Healthcare Ltd. Medical/Nursing ServicesHealth Services Roche Healthcare Ltd. provides residential and nursing services. It offers care homes, home care support, and Roche training solutions. The company was founded by Patrick Roche in 1995 and is headquartered in Leeds, the United Kingdom. | Medical/Nursing Services | Corporate Officer/Principal | |
MEREO BIOPHARMA GROUP PLC | Biotechnology | Director/Board Member | |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer | |
RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tilos Therapeutics, Inc.
Tilos Therapeutics, Inc. BiotechnologyHealth Technology Tilos Therapeutics, Inc. designs and develops biotechnology products such as developing new treatments for cancer, fibrosis and autoimmune disease. It develops antibody therapeutics that target key immunological pathways, with a primary focus on regulatory T cells and regulation of effector cells. The company was founded by Howard L. Weiner in 2016 and is headquartered in Lexington, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
FUSN PHAR | Pharmaceuticals: Major | Director/Board Member | |
Belfer Center for Applied Cancer Science
Belfer Center for Applied Cancer Science Miscellaneous Commercial ServicesCommercial Services The Belfer Center for Applied Cancer Science operates a cancer research center. The non-profit company is based in Boston, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bakx Therapeutics is a company based in DE that focuses on developing more effective and precise therapeutics that utilize the mitochondrial apoptosis pathway. The American company's proprietary codynx™ drug discovery platform integrates computational and experimental capabilities to collaborate with researchers in validated biological pathways. Bakx's leading asset, partnered with Ipsen, is focused on activating the bax protein to treat cancer and age-related diseases. Bakx Therapeutics, Inc. was co-founded by world-leading researchers in apoptosis and computationally aided drug discovery. Sree Kant has been the CEO of the company since 2020. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
PrismBio, Inc.
PrismBio, Inc. Air Freight/CouriersTransportation PrismBio, Inc. is a company that provides natural colorants that are renewably and sustainably produced. The company is based in Kent, DE and was founded by Troy Wilson, Justin Siegel, J. Clark Lagarias, Thomas R. Baruch, and Glenn E. Nedwin. The company's product line of colorants can be created in any shade of the visible spectrum and are customizable, stabile, and sustainably made. The company offers three kinds of natural colorants: colorfast, colorswitch, and colorbranding. Troy Wilson has been the CEO since incorporation. | Air Freight/Couriers | Founder |
Statistieken
Internationaal
Verenigde Staten | 40 |
Verenigd Koninkrijk | 4 |
Canada | 3 |
Australië | 2 |
Italië | 2 |
Sectoraal
Health Technology | 29 |
Consumer Services | 11 |
Commercial Services | 5 |
Health Services | 3 |
Finance | 3 |
Operationeel
Corporate Officer/Principal | 16 |
Director/Board Member | 11 |
Chief Tech/Sci/R&D Officer | 8 |
Doctorate Degree | 6 |
Undergraduate Degree | 5 |
Sterkste connecties
Insiders | |
---|---|
Jeremy Bender | 12 |
Glenn E. Nedwin | 10 |
Jessie English | 10 |
Steve Young | 8 |
Nicki Vasquez | 6 |
Matthew McClure | 5 |
Yvonne Gehring | 3 |
Bao Le | 2 |
- Beurs
- Insiders
- Anupama Hoey
- Bedrijfsconnecties